iCAC Device vs cvi42 Auto Imaging
AI Verdict
Choose iCAC Device if…
Choose iCAC Device if your primary goal is opportunistic screening for cardiovascular disease by leveraging existing, routine non-contrast chest CT scans. This tool is ideal for identifying patients at risk of coronary artery disease without requiring additional dedicated cardiac imaging, integrating seamlessly into existing radiology workflows to provide early CAC detection.
View iCAC Device →Choose cvi42 Auto Imaging if…
Choose cvi42 Auto Imaging if you require comprehensive, multi-modality analysis for dedicated cardiovascular MR and CT studies. This software is best suited for in-depth assessment of cardiac function, flow, tissue characterization, and detailed plaque quantification, empowering precise diagnosis and treatment planning for complex cardiovascular conditions.
View cvi42 Auto Imaging →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | iCAC Device | cvi42 Auto Imaging |
|---|---|---|
| Pricing | Contact for pricing | Starts at $5000 per license |
| Deployment | Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform). | On-premise (standalone workstation or client/server) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
cvi42 Auto ImagingTool B (cvi42 Auto Imaging) offers AI-enabled automated contouring and segmentation, 3D visualization, multiplanar reconstruction, and simplified reporting with infographics and CAD-RADS classification. This comprehensive suite of features, coupled with multi-modality and vendor-neutral compatibility, suggests a more intuitive and versatile user experience for a broader range of complex cardiovascular imaging tasks compared to Tool A's more specialized output.
Clinical Value
cvi42 Auto ImagingWhile Tool A (iCAC Device) provides significant clinical value by opportunistically detecting CAC from routine CT scans for early cardiovascular disease detection, Tool B (cvi42 Auto Imaging) offers a much broader and deeper range of clinical applications. It covers comprehensive analysis of cardiovascular MR and CT images, including detailed cardiac function, flow, tissue characterization, strain, coronary artery analysis, and plaque assessment, thus addressing a wider spectrum of cardiovascular diagnostics.
Pricing & Value
TieBoth tools require direct contact with the vendor for pricing information, making it impossible to conduct a head-to-head comparison on cost. Tool B mentions modular licensing, which could lead to varying costs depending on the features required, but without transparent pricing for either, a definitive winner cannot be determined.
Enterprise Readiness
cvi42 Auto ImagingTool B (cvi42 Auto Imaging) offers flexible deployment options, including on-premise, standalone, and networked environments, with an emphasis on on-premise for data control, which is crucial for many enterprises. Its multi-modality and vendor-neutral compatibility also enhance its ability to integrate into diverse existing IT infrastructures. Tool A is primarily cloud-based, which may be less flexible for organizations with strict on-premise data requirements.
Innovation
cvi42 Auto ImagingTool A's (iCAC Device) innovation lies in its opportunistic detection of CAC from routine, non-contrast, non-gated chest CT scans, leveraging existing data for early detection. However, Tool B (cvi42 Auto Imaging) demonstrates a broader and deeper application of AI across multiple imaging modalities (MR and CT) and complex cardiovascular analyses, including advanced features like automated contouring, strain analysis, and comprehensive plaque quantification, indicating a higher overall level of innovative AI application.
Support & Docs
cvi42 Auto ImagingTool B (cvi42 Auto Imaging) explicitly features a 'Support' section on its website, which includes access to documentation and outlines dedicated resources for customer assistance and training. In contrast, Tool A (iCAC Device) does not provide specific details about its support structure or documentation in the provided facts or readily available on its website beyond general contact information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | iCAC Device | cvi42 Auto Imaging |
|---|---|---|
| Product Name | iCAC Device | cvi42 Auto Imaging |
| Company | Bunkerhill Health | Circle Cardiovascular Imaging |
| Primary Function | Detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans. | AI-powered software for comprehensive analysis of cardiovascular MR and CT images, aiding in precise diagnosis, plaque quantification, and streamlined clinical workflows. |
| Supported Modalities/Scans | Routine, non-contrast, non-gated chest CT scans. | Cardiac MR, Cardiac CT, Vascular CT (Multi-modality support: MR, CT). |
| Key Output/Quantification | Exact and four-category quantitative estimates of CAC burden in Agatston units; visual representation of estimated CAC segmentation. | Quantitative analysis (volume, mass, function, signal intensity, plaque); simplified and smart reporting with infographics and CAD-RADS classification. |
| BBA Availability | contact vendor for details | not explicitly stated, but implied for HIPAA compliance, especially for cloud-based components or data processing involving protected health information (PHI). |
Videos
Demos, reviews, and walkthroughs featuring iCAC Device and cvi42 Auto Imaging.